This test pre-emptively determines the risks of developing a wide range of hereditary cancers currently included in international databases:
- Whole-Exome Analysis - All hereditary cancers and their associated pathogenic genetic variants included in international databases (including Clin Var and OMIM) will reviewed
- Gene-specific analysis - a specific list of cancer genes will also be analyzed
- Only pathogenic or likely-pathogenic genetic variants will be reported. If symptoms are provided, variants of uncertain clinical significance (VUS) will also be reported.
- Using 22,000 genes from your exome

Purchase Remarks: Doctors to conduct health consultation, physical examination and result report interpretation.